CVI Holdings’s Kindred Biosciences, Inc. KIN Stock Holding History

CVI Holdings’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-45,057	Closed	-$480K	–	60
2018 Q2	$480K	Buy	+45,057	New	+$439K	0.6%	24

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

CVI Holdings's KIN Position: Q3 2018 in Review

CVI Holdings sold out of Kindred Biosciences, Inc. (KIN) in Q3 2018, closing a stake of 45,057 shares — an estimated $480K sold.

CVI Holdings first reported a position in KIN in Q2 2018 and held it in 1 quarter. The position peaked at $480K in Q2 2018. 81 funds tracked by Wall St. Rank hold KIN as of Q3 2018.

CVI Holdings reported no remaining Kindred Biosciences, Inc. position as of Q3 2018 after selling out during the quarter.
CVI Holdings sold 45,057 Kindred Biosciences, Inc. shares in Q3 2018, an estimated $480K.
CVI Holdings first reported a position in Kindred Biosciences, Inc. in Q2 2018 and held it in 1 quarter.
CVI Holdings's Kindred Biosciences, Inc. position peaked at $480K in Q2 2018.
81 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2018.

Based on CVI Holdings's 13F filing for Q3 2018, filed 14 Nov 2018.